Skip to main content
. 2019 May 17;6(4):667–677. doi: 10.1002/ehf2.12448

Figure 2.

Figure 2

Study groups and primary/secondary endpoints. Note: HF, heart failure; NT‐proBNP, N‐terminal pro‐brain‐type natriuretic peptide; PEF, peak expiratory flow; PGA, patient global assessment; R, randomization; SpO2, peripheral oxygen saturation level; VAS, visual analogue scale.